不明原因不孕 中国就医指南

Unexplained infertility is a clinical diagnosis assigned to couples who have failed to achieve pregnancy after at least 12 months of regular, unprotected intercourse—and for whom comprehensive fertility evaluation reveals no identifiable cause. This diagnosis applies only after thorough assessment of both partners, including semen analysis, ovarian reserve testing (AMH, AFC, FSH), ovulation confirmation, hysterosalpingography or sonohysterography to evaluate tubal patency and uterine anatomy, and endometrial assessment where indicated. Despite advances in reproductive medicine, approximately 10–30% of infertile couples worldwide receive this diagnosis—making it one of the most common indications for assisted reproductive technology (ART) in specialized reproductive medicine departments. The pathogenesis remains elusive but is thought to involve subtle, multifactorial disruptions: subclinical oocyte or sperm dysfunction (e.g., impaired chromatin integrity, mitochondrial inefficiency, or epigenetic dysregulation), minor endometrial receptivity defects not detectable by standard histology or imaging, undiagnosed immunologic factors (e.g., natural killer cell dysregulation or anti-endometrial antibodies), or transient hormonal imbalances affecting embryo-endometrium synchrony. Emerging evidence also implicates oxidative stress, microbiome dysbiosis in the upper genital tract, and genetic polymorphisms influencing folliculogenesis or implantation pathways. Epidemiologically, unexplained infertility affects roughly 1 in 15 couples of reproductive age globally, with prevalence rising in high-income countries due to delayed childbearing and increased diagnostic scrutiny. Risk factors include advanced maternal age (≥35 years), mild obesity (BMI 25–30), chronic low-grade inflammation, psychological stress, environmental toxin exposure (e.g., phthalates, BPA), and lifestyle factors such as smoking, excessive caffeine intake, or sedentary behavior—though none are causative alone. Importantly, male factors contribute significantly in up to 40% of cases previously labeled 'unexplained', underscoring the need for advanced sperm function testing (e.g., DNA fragmentation assay). The psychosocial burden is profound: patients frequently report elevated anxiety, depression, marital strain, diminished sexual intimacy, and feelings of inadequacy or stigma—particularly in cultures where fertility is tightly linked to identity and social standing. Quality of life metrics consistently show lower scores in domains of emotional well-being, social functioning, and vitality compared to fertile peers or even those with diagnosed infertility causes. Without intervention, spontaneous conception rates remain modest—approximately 15–25% over two years—but prognosis improves markedly with evidence-based management, including expectant monitoring with timed intercourse, ovulation induction with clomiphene or letrozole, intrauterine insemination (IUI), or in vitro fertilization (IVF), which offers the highest per-cycle success rate (40–55% live birth rate per cycle in women under 35). Early referral to reproductive endocrinology and infertility (REI) specialists ensures timely escalation and personalized care aligned with patient values, timelines, and financial considerations.

# 不明原因不孕治疗方案与费用明细（生殖医学科）

一、非手术/保守治疗方案

• •基础监测+生活方式干预：适用于初诊、年轻（<35岁）、无合并症者；含月经周期监测、精液常规、激素六项、输卵管通液试验；费用：1,200–2,800元（含检查费）。
• •促排卵联合指导同房（CC/来曲唑）：适用于卵巢储备正常、排卵障碍倾向者；含B超卵泡监测（4–6次）、血清E₂/P检测；费用：3,500–6,200元。
• •宫腔内人工授精（IUI）：需男方精液优化、女方输卵管通畅；含术前感染筛查、精子处理、IUI操作及黄体支持；费用：8,500–12,000元/周期（含检查费2,000元）。

二、手术/微创介入方案

• •宫腹腔镜联合探查术：适用于IUI失败≥3周期、可疑盆腔粘连/子宫内膜息肉者；含术前全麻评估、术中染色通液、活检及微创处理；费用：28,000–38,000元（含术前检查费4,500元）。

三、特殊复杂/耐药/复发方案

• •IVF-ET（常规体外受精）：适用于IUI失败≥3周期或年龄≥35岁；含长方案/拮抗剂方案、取卵、胚胎培养、鲜胚/冻胚移植；费用：32,000–45,000元/周期（含基因筛查PGT-A另计12,000–18,000元）。

四、方案快速选择指南

• •预算≤1万元/年：首选基础监测+IUI（1–2周期）；
• •预算2–4万元+年龄<35岁：推荐IUI 3周期后直接IVF；
• •反复失败/≥38岁/卵巢储备下降：首推IVF，避免延迟。